The nation of Zimbabwe has turned down a major American healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to Washington's request for confidential data.
This move came to light after a official document dated December was disclosed, revealing that President Emmerson Mnangagwa believed the deal was "skewed".
A government representative has since stated that the United States was seeking biological samples for scientific study and commercial gain but was not willing to share the resulting advantages from any future treatments.
"We are forced to start the difficult and regrettable process of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had furnished over $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for continued negotiations to reach a agreement acceptable to both sides so the nation's critical HIV programme can proceed.
Broader Context
Zimbabwe's decision comes after a similar case in Kenya, where a high court suspended a related deal with the US following concerns were filed about the safety of Kenyans' health data.
After returning to the presidency last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had overseen assistance for the American government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government agreements to enhance openness and accountability.
As per reports, 16 African countries have to date agreed to these new health pacts, representing over $18.3bn in new funding.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently on HIV treatment via American-funded programmes," the Ambassador said.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"Our nation was requested to provide its genetic material and health information indefinitely, without any corresponding promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," Mangwana explained.
"In essence, our nation would supply the raw materials for scientific discovery with no assurance that the end products would be accessible to our citizens should a new disease outbreak emerge."
National Interest and Global Health
Mangwana further said that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining systems previously set up via the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system created to deal with potential global health emergencies.
"This system is intended to guarantee that when a nation contributes its information, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the capability to create them."
These objections regarding the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome ongoing discussions with our US partners on how future collaboration might be arranged in a way that honours the sovereignty and interests of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but recommended that talks must proceed since a large portion of the nation's Aids initiatives relied on international support.
"If technical issues arise, such as those relating to information security or agreement terms, these can often be addressed via technical clarification and mutually agreed protections," it commented.
The halted deal emphasises the ongoing challenges between receiving crucial foreign assistance and protecting local interests in an increasingly interconnected world.